Progress in cardiovascular biology: PPAR for the course

被引：54

作者：

Lazar, MA ^{[1
]}

机构：

[1] Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA

[2] Univ Penn, Sch Med, Dept Genet, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA

[3] Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA

来源：

NATURE MEDICINE | 2001年 / 7卷 / 01期

关键词：

D O I：

10.1038/83301

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Studies on mice lacking the peroxisome proliferator-activated receptor (PPAR) suggest that PPAR ligands reduce lipid accumulation in foamy macrophages, and may target other receptors. These findings warrant an in-depth investigation into the gene regulatory mechanisms of PPAR ligands, which are currently being developed as drugs to treat atherosclerosis and diabetes.

引用

页码：23 / 24

页数：2

共 12 条

[1] PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation [J].

Chawla, A ;

Barak, Y ;

Nagy, L ;

Liao, D ;

Tontonoz, P ;

Evans, RM .

NATURE MEDICINE, 2001, 7 (01) :48-52

[2] PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].

Chinetti, G ;

Lestavel, S ;

Bocher, V ;

Remaley, AT ;

Neve, B ;

Torra, IP ;

Teissier, E ;

Minnich, A ;

Jaye, M ;

Duverger, N ;

Brewer, HB ;

Fruchart, JC ;

Clavey, V ;

Staels, B .

NATURE MEDICINE, 2001, 7 (01) :53-58

[3] PPAR-γ agonists inhibit production of monocyte inflammatory cytokines [J].

Jiang, CY ;

Ting, AT ;

Seed, B .

NATURE, 1998, 391 (6662) :82-86

[4] The role of PPAR-γ in macrophage differentiation and cholesterol uptake [J].

Moore, KJ ;

Rosen, ED ;

Fitzgerald, ML ;

Randow, F ;

Andersson, LP ;

Altshuler, D ;

Milstone, DS ;

Mortensen, RM ;

Spiegelman, BM ;

Freeman, MW .

NATURE MEDICINE, 2001, 7 (01) :41-47

[5] Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ [J].

Nagy, L ;

Tontonoz, P ;

Alvarez, JGA ;

Chen, HW ;

Evans, RM .

CELL, 1998, 93 (02) :229-240

[6] Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists [J].

Olefsky, JM .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04) :467-472

[7] Transcriptional control of adipogenesis [J].

Rangwala, SM ;

Lazar, MA .

ANNUAL REVIEW OF NUTRITION, 2000, 20 :535-559

[8] The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation [J].

Ricote, M ;

Li, AC ;

Willson, TM ;

Kelly, CJ ;

Glass, CK .

NATURE, 1998, 391 (6662) :79-82

[9] Peroxisome proliferator-activated receptor γ ligands and atherosclerosis:: ending the heartache [J].

Rosen, ED ;

Spiegelman, BM .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (05) :629-631

[10] Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase [J].

Rossi, A ;

Kapahi, P ;

Natoli, G ;

Takahashi, T ;

Chen, Y ;

Karin, M ;

Santoro, MG .

NATURE, 2000, 403 (6765) :103-108

← 1 2 →